![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Ann R Coll Surg Engl |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Bilateral obstructive megaureter with right lower ureteric urothelial carcinoma:
a very rare coalition.
Ann R Coll Surg Engl. 2022;104:e153-e155.
PubMed
Abstract available
Systematic Review and Meta-Analysis of Inguinal Versus Classic Obturator Nerve
Block.
Asian J Anesthesiol. 2022;60:1-10.
PubMed
Abstract available
Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive
bladder cancer-analysis of adverse effects and effectiveness of two strains of
BCG (Danish 1331 and Moscow-I).
Asian J Urol. 2022;9:157-164.
PubMed
Abstract available
The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non
Neoplastic Urothelium; and a Correlation with the Tumor Features.
Asian Pac J Cancer Prev. 2022;23:1425-1432.
PubMed
Abstract available
Effects of Proton Pump Inhibitors on Survival Outcomes in Patients with
Metastatic or Unresectable Urothelial Carcinoma Treated with Pembrolizumab.
Biol Pharm Bull. 2022;45:590-595.
PubMed
Abstract available
Sex differences in the aging murine urinary bladder and influence on the tumor
immune microenvironment of a carcinogen-induced model of bladder cancer.
Biol Sex Differ. 2022;13:19.
PubMed
Abstract available
Do we need repeat TUR after en bloc resection for pT1 bladder cancer?
BJU Int. 2022 Apr 29. doi: 10.1111/bju.15760.
PubMed
Abstract available
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in
FGFR3 fusion-driven bladder cancer.
BMC Cancer. 2022;22:478.
PubMed
Abstract available
ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via
downregulating HIC1 expression.
Cancer Cell Int. 2022;22:179.
PubMed
Abstract available
What is the impact of dynamic contrast-enhancement sequence in the Vesical
Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.
Cancer Imaging. 2022;22:20.
PubMed
Abstract available
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated
m6A Modification of PD-L1 mRNA.
Cancer Res. 2022;82:1789-1802.
PubMed
Abstract available
Anti-cancer effect of LINC00478 in bladder cancer correlates with KDM1A-dependent
MMP9 demethylation.
Cell Death Discov. 2022;8:242.
PubMed
Abstract available
circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5.
Cell Death Discov. 2022;8:243.
PubMed
Abstract available
Micturition-triggered severe headache associated with bladder paraganglioma: A
case report.
Cephalalgia. 2022;42:166-169.
PubMed
Abstract available
Cold Spring Harb Mol Case Stud
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic
sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
Cold Spring Harb Mol Case Stud. 2022;8.
PubMed
Abstract available
Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder
Urothelial Carcinoma via Inhibition of KLF9.
Comput Math Methods Med. 2022;2022:8911343.
PubMed
Abstract available
Epigenetics, environment and epidemiology: an interview with Karl Kelsey.
Epigenomics. 2022;14:323-326.
PubMed
Abstract available
The clinical utility of comprehensive measurement of autoimmune disease-related
antibodies in patients with advanced solid tumors receiving immune checkpoint
inhibitors: a retrospective study.
ESMO Open. 2022;7:100415.
PubMed
Abstract available
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint
blockade in metastatic urothelial carcinoma.
Eur J Cancer. 2022;167:13-22.
PubMed
Abstract available
Robot-assisted-radical-cystectomy with total intracorporeal Y neobladder:
Analysis of postoperative complications and functional outcomes with urodynamics
findings.
Eur J Surg Oncol. 2022;48:694-702.
PubMed
Abstract available
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as
Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive
Bladder Cancer.
Eur Urol. 2022 Apr 30. pii: S0302-2838(22)01816.
PubMed
Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The
Urologist Still Has a Role in Genetic Screening.
Eur Urol Oncol. 2022;5:42-43.
PubMed
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A
Comprehensive Overview from the European Association of Urology - Young Academic
Urologists and the Global Society of Rare Genitourinary Tumors.
Eur Urol Oncol. 2022;5:30-41.
PubMed
Abstract available
STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with
Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.
Eur Urol Open Sci. 2022;38:88-95.
PubMed
Abstract available
Effect of glycated HDL on oxidative stress and cholesterol homeostasis in a human
bladder cancer cell line, J82.
Exp Mol Pathol. 2022 Apr 29:104777. doi: 10.1016/j.yexmp.2022.104777.
PubMed
Abstract available
Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of
Muscle-Invasive Bladder Cancer: A Review of Literature.
Front Oncol. 2022;12:816444.
PubMed
Abstract available
Editorial: Recent Advances in Bladder Cancer Diagnosis and Treatment.
Front Surg. 2022;9:890172.
PubMed
Complications and their management following retroperitoneal lymph node
dissection in conjunction with retroperitoneal laparoscopic radical
nephroureterectomy.
Int J Urol. 2022;29:455-461.
PubMed
Abstract available
Life expectancy in metastatic urothelial bladder cancer patients according to
race/ethnicity.
Int Urol Nephrol. 2022 May 4. pii: 10.1007/s11255-022-03221.
PubMed
Abstract available
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective
bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of
bladder.
Investig Clin Urol. 2022;63:168-174.
PubMed
Abstract available
Classification of tissue biopsies by Raman spectroscopy guided by quantitative
phase imaging and its application to bladder cancer.
J Biophotonics. 2022 Apr 30:e202200009. doi: 10.1002/jbio.202200009.
PubMed
Abstract available
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune
responses in bladder cancer.
J Clin Invest. 2022 May 3. pii: 145666. doi: 10.1172/JCI145666.
PubMed
Abstract available
Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression
confers aggressiveness and independently predicts recurrence in bladder
urothelial carcinomas.
J Histotechnol. 2021;44:196-205.
PubMed
Abstract available
Prognostic significance of EZH2 and ARID1A expression in urothelial carcinoma: an
immunohistochemical study.
J Histotechnol. 2022;45:21-28.
PubMed
Abstract available
Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in
patients with primary prostate cancer.
J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
PubMed
Abstract available
Identification of Potential Biomarkers for Progression and Prognosis of Bladder
Cancer by Comprehensive Bioinformatics Analysis.
J Oncol. 2022;2022:1802706.
PubMed
Abstract available
Urothelial carcinoma with tonsillar metastasis in a dog.
J Vet Diagn Invest. 2022;34:564-567.
PubMed
Abstract available
Downregulation of m(6) A writer complex member METTL14 in bladder urothelial
carcinoma suppresses tumor aggressiveness.
Mol Oncol. 2022;16:1841-1856.
PubMed
Abstract available
Granulomatous renal affectation post-BCG treatment of bladder tumor.
Radiologia (Engl Ed). 2022;64:179-181.
PubMed
[How has the Paris System contributed to urine cytology? Evaluating the
contribution of the Paris System to urine cytology. A comparative study of the
Paris System and the Papanicolaou method in a tertiary centre].
Rev Esp Patol. 2022;55:125-134.
PubMed
Abstract available
Contacts to general practice in the 12 months preceding a diagnosis of an
abdominal cancer: a national register-based cohort study.
Scand J Prim Health Care. 2022;40:148-156.
PubMed
Abstract available
Primary versus secondary muscle-invasive bladder cancer: survival after curative
treatment.
Scand J Urol. 2022 May 4:1-7. doi: 10.1080/21681805.2022.2056633.
PubMed
Abstract available
Increased NUSAP1 expression is associated with lymph node metastasis and survival
prognosis in bladder urothelial carcinoma.
Sci Rep. 2022;12:7003.
PubMed
Abstract available
MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by
regulating WNT5A/beta-catenin signaling.
Sci Rep. 2022;12:6955.
PubMed
Abstract available
A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of
bladder cancer.
Sci Rep. 2022;12:7017.
PubMed
Abstract available
Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in
Bladder Cancer.
Technol Cancer Res Treat. 2022;21:15330338221090093.
PubMed
Abstract available
PIxel-Level Segmentation of Bladder Tumors on MR Images Using a Random Forest
Classifier.
Technol Cancer Res Treat. 2022;21:15330338221086395.
PubMed
Abstract available
Bladder granulocytic sarcoma in a child: case report and literature review.
Turk J Pediatr. 2022;64:152-159.
PubMed
Abstract available
[Intravesical gemcitabine for non-muscle invasive bladder cancer].
Urologe A. 2022 May 4. pii: 10.1007/s00120-022-01840.
PubMed
Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing
Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath
Protective?
Urology. 2022;160:142-146.
PubMed
Abstract available
Detection Rate of Carcinoma In Situ During TURBT Following Shift from
Photodynamic Diagnosis to Narrow Band Imaging in a Single University Hospital.
Urology. 2022;161:83-86.
PubMed
Abstract available
Lip Metastasis After Radical Cystectomy.
Urology. 2022;161:17-18.
PubMed
Bladder Necrosis at Time of Presentation with Ulcerative Colitis in an 8-year-old
Female: A Case Report.
Urology. 2022;160:195-198.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by